No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ALPN Alpine Immune
- 64.660
- +0.100+0.15%
Trading Apr 29 15:39 ET
4.24BMarket Cap-101031P/E (TTM)
64.680High64.570Low985.85KVolume64.610Open64.560Pre Close63.74MTurnover2.19%Turnover RatioLossP/E (Static)65.56MShares64.70052wk High12.93P/B2.91BFloat Cap7.25052wk Low--Dividend TTM44.94MShs Float81.720Historical High--Div YieldTTM0.17%Amplitude2.050Historical Low64.650Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
$100B Vertex Pharma Working To Recreate $10B Cystic Fibrosis Success - This Time Focused On Pain Management Drugs
Vertex Pharmaceuticals Inc's (NASDAQ:VRTX) blockbuster drug Trikafta for cystic fibrosis (CF) has shown remarkable efficacy, potentially extending the lives of some patients by up to 45 years. Despite
Vertex Doesn't Seem To Have Engaged With Other Players Before Alpine Deal -- Market Talk
1454 ET - Vertex Pharmaceuticals seems not to have explored alternatives before its deal for kidney-disease treatment developer Alpine. Evercore ISI analysts Liisa Bayko and Jingming Chen say in a res
ProKidney Sinks 15%+, Snapping Five-Session Run-Up That Saw Biotech More Than Double in Less Than a Week
PROK sank more than 15% Thursday as the biotech snapped a five-session winning streak that saw its price rise some 130% in just days.
ProKidney Stock Soars 30%+ Tuesday and Nearly 90% in Less Than a Week
ProKidney rose more than 30% Tuesday as the biotech firm rallied for the fourth straight session – a run-up that's seen the stock rise nearly 90% in less than a week.
Alpine Immune Sciences Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/16/2024 — TD Cowen Downgrades Buy → Hold 04/12/2024 0.9% Leerink Partners $42 → $65 Downgrades Outperf
Express News | Alpine Immune Sciences Inc : TD Cowen Cuts to Hold From Buy
Comments
$Alpine Immune(ALPN.US$
🤩🤩🤩 SELL ALL IN APRIL AND TRAVEL (+ 💰💰💰💰💰) THEN SELL ALL AGAIN IN MAY (- $$$$$$ ) AND RUN AWAY 😭😭😭
47. G = Make Money From Thin Air, Block Short, Keep Repeating (Pump and Drop) to trap Buyers or Create Fake Symbols to Rob Money From Investors
47. T = Track and Kill by Weapons, Dark Magics, Nightmare, Accident, Sickness, Burn, Drown....them, and kill their children too, if they teach their children the same
🤩🤩🤩 SELL ALL IN APRIL AND TRAVEL (+ 💰💰💰💰💰) THEN SELL ALL AGAIN IN MAY (- $$$$$$ ) AND RUN AWAY 😭😭😭
47. G = Make Money From Thin Air, Block Short, Keep Repeating (Pump and Drop) to trap Buyers or Create Fake Symbols to Rob Money From Investors
47. T = Track and Kill by Weapons, Dark Magics, Nightmare, Accident, Sickness, Burn, Drown....them, and kill their children too, if they teach their children the same
ColumnsProKidney Sinks 15%+, Snapping Five-Session Run-Up That Saw Biotech More than Double in Less Than a Week
$ProKidney(PROK.US$ sank more than 15% Thursday as the biotech snapped a five-session winning streak that saw its price rise some 130% in just days.
PROK fell 15.5% to close at $2.40, ending a run-up that began last Thursday, April 11, despite no apparent news.
Shares gained 132.4% between the stock's $1.45 close on April 10 and its $3.37 peak this past Wednesday.
ProKidney, which is trying t...
PROK fell 15.5% to close at $2.40, ending a run-up that began last Thursday, April 11, despite no apparent news.
Shares gained 132.4% between the stock's $1.45 close on April 10 and its $3.37 peak this past Wednesday.
ProKidney, which is trying t...
7
ColumnsProKidney Soars 30%+ Tuesday and Nearly 90% in Less Than a Week
$ProKidney(PROK.US$ rose more than 30% Tuesday as the biotech firm rallied for the fourth straight session – a run-up that's seen the stock rise nearly 90% in less than a week.
PROK gained 30.1% to close at $2.72, up 87.6% from last Wednesday's close at $1.45.
ProKidney has been soaring despite no news announcements, although the stock's rally began the day after $Vertex Pharmaceuticals(VRTX.US$ unveiled plans to buy biotech $Alpine Immune(ALPN.US$ for $4.9 ...
PROK gained 30.1% to close at $2.72, up 87.6% from last Wednesday's close at $1.45.
ProKidney has been soaring despite no news announcements, although the stock's rally began the day after $Vertex Pharmaceuticals(VRTX.US$ unveiled plans to buy biotech $Alpine Immune(ALPN.US$ for $4.9 ...
4
Recently announced M&As in April 2024
$Aditxt(ADTX.US$ to acquire Appili Tx
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
What companies will be next? 🤔
TuHURA Biosciences merger w/ $Kintara Therapeutics(KTRA.US$
$Johnson & Johnson(JNJ.US$ to acquire $ShockWave Medical(SWAV.US$
$Vertex Pharmaceuticals(VRTX.US$ to acquire $Alpine Immune(ALPN.US$
What companies will be next? 🤔
5
ColumnsToday's Morning Movers and Top Ratings: NKE, AMZN, KMX, V and More
Morning Movers
Gapping up
$Nike(NKE.US$ stock increased by 1.4% after the sportswear company revealed its Olympic kits, aiming to leverage the appeal of top athletes to attract more consumers.
$Alpine Immune(ALPN.US$ stock surged over 36% after Vertex Pharmaceuticals announced its plan to acquire the biotech company for about $4.9 billion in cash, which would give Vertex access to a treatment for an autoimmune kidney disease.
$Rent the Runway(RENT.US$ stock ju...
Gapping up
$Nike(NKE.US$ stock increased by 1.4% after the sportswear company revealed its Olympic kits, aiming to leverage the appeal of top athletes to attract more consumers.
$Alpine Immune(ALPN.US$ stock surged over 36% after Vertex Pharmaceuticals announced its plan to acquire the biotech company for about $4.9 billion in cash, which would give Vertex access to a treatment for an autoimmune kidney disease.
$Rent the Runway(RENT.US$ stock ju...
28
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg